| Source HCPCS Code |
|
Target NDC Code |
Q4092
|
⇄
|
00026-0645-12
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q4092
|
⇄
|
00026-0645-15
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q4092
|
⇄
|
00026-0645-20
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q4092
|
⇄
|
00026-0645-24
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q4092
|
⇄
|
00026-0645-71
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q4092
INJECTION, IMMUNE GLOBULIN (GAMUNEX), INTRAVENOUS, NON-LYOPHILIZED (E.G. LIQUID), 500 MG
|
⇄
|
13533-0645-12
GAMUNEX (PF) 100 MG/ML
|
| Detail Information |
| Relationship Start Date |
7/1/2007 |
| Relationship End Date |
12/31/2007 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q4092
INJECTION, IMMUNE GLOBULIN (GAMUNEX), INTRAVENOUS, NON-LYOPHILIZED (E.G. LIQUID), 500 MG
|
⇄
|
13533-0645-15
GAMUNEX (PF) 100 MG/ML
|
| Detail Information |
| Relationship Start Date |
7/1/2007 |
| Relationship End Date |
12/31/2007 |
| Number Of Items In Ndc Package |
25 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q4092
INJECTION, IMMUNE GLOBULIN (GAMUNEX), INTRAVENOUS, NON-LYOPHILIZED (E.G. LIQUID), 500 MG
|
⇄
|
13533-0645-20
GAMUNEX (PF) 100 MG/ML
|
| Detail Information |
| Relationship Start Date |
7/1/2007 |
| Relationship End Date |
12/31/2007 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q4092
INJECTION, IMMUNE GLOBULIN (GAMUNEX), INTRAVENOUS, NON-LYOPHILIZED (E.G. LIQUID), 500 MG
|
⇄
|
13533-0645-24
GAMUNEX (PF) 100 MG/ML
|
| Detail Information |
| Relationship Start Date |
7/1/2007 |
| Relationship End Date |
12/31/2007 |
| Number Of Items In Ndc Package |
200 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q4092
INJECTION, IMMUNE GLOBULIN (GAMUNEX), INTRAVENOUS, NON-LYOPHILIZED (E.G. LIQUID), 500 MG
|
⇄
|
13533-0645-71
GAMUNEX (PF) 100 MG/ML
|
| Detail Information |
| Relationship Start Date |
7/1/2007 |
| Relationship End Date |
12/31/2007 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|